You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 5, May 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Cognitive Disorders
 •Dementias
 •Neurology, Other
 •Psychiatry
 •Depression
 •Alert me on articles by topic

Patient's Rating of Cognitive Ability

Using the AD8, a Brief Informant Interview, as a Self-rating Tool to Detect Dementia

James E. Galvin, MD, MPH; Catherine M. Roe, PhD; Mary A. Coats, RN, MSN; John C. Morris, MD

Arch Neurol. 2007;64(5):725-730.

Objective  To test the ability of patients to rate their own cognitive ability using the AD8 compared with informant and clinician ratings of cognitive status.

Design, Setting, and Patients  The AD8 was administered to 325 consecutive participant-informant dyads enrolled in a longitudinal study at Washington University School of Medicine between April 4, 2005, and December 15, 2005. The number of AD8 items endorsed by the participant was compared with informant answers and an independently derived Clinical Dementia Rating.

Main Outcome Measure  Strength of association was measured with Spearman ({rho}) and intraclass correlation coefficients. Receiver operator characteristic curves assessed the discriminative properties of the AD8.

Results  The mean age of participants and informants was 72.8 years (range, 43-104 years) and 66.4 years (range, 24-101 years), respectively. The Clinical Dementia Rating was correlated with both informant ({rho} = 0.75, P<.001) and participant ({rho} = 0.34, P<.001) AD8 scores. Participants' AD8 scores had adequate agreement with informants' AD8 scores (intraclass correlation coefficient, 0.53; 95% confidence interval, 0.41-0.62) and correlated with subjective complaints of memory problems ({rho} = 0.47, P<.001) but not with estimates of symptom duration. The area under the receiver operator characteristic curve for the informant AD8 was 0.89 (95% confidence interval, 0.86-0.93); for the participant AD8, it was 0.78 (95% confidence interval, 0.68-0.78).

Conclusions  The AD8 is a brief measure that, when completed by an informant, differentiates nondemented from demented individuals. We now demonstrate that a self-completed AD8 also differentiates nondemented from demented individuals, although the utility was better in mildly impaired individuals compared with more demented individuals. In the absence of a reliable informant, the AD8 may be asked of the participant to gain an understanding of their perception of cognitive status.


Author Affiliations: Departments of Neurology (Drs Galvin and Morris and Ms Coats), Anatomy and Neurobiology (Dr Galvin), and Pathology and Immunology (Dr Morris); Division of Biostatistics (Dr Roe); and the Alzheimer Disease Research Center (Drs Galvin, Roe, and Morris and Ms Coats), Washington University School of Medicine, St Louis, Mo.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.